Immune Globulin Intravenous (Human) (Systemic)
Brand Names : Gamimune N 5%, Gamimune N 10%, Gamimune N 5% S/D, Gamimune N 10% S/D, Gammagard S/D, Gammagard S/D 0.5 g, Gammar-P IV, Iveegam, Panglobulin, Polygam S/D, Sandoglobulin, Venoglobulin–I, Venoglobulin-S, IGIV, IVIG
Additional InformationOnce a medicine has been approved for marketing
for a certain use, experience may show that it is also useful for other medical
problems. Although these uses are not included in product labeling, IGIV is
used in certain patients with the following medical conditions:
-
Chronic parvovirus B19 infection (treatment)
-
Chronic inflammatory demyelinating polyneuropathies (treatment)
-
Dermatomyositis (treatment)
-
Guillain-Barr� syndrome (treatment)
-
Hyperimmunoglobulinemia E syndrome (treatment)
-
Infections in low-birth-weight preterm high-risk neonates (prophylaxis
and treatment adjunct)
-
Lambert-Eaton myasthenic syndrome (treatment)
-
Multifocal motor neuropathy (treatment)
-
Relapsing-remitting multiple sclerosis (treatment)
Other than the above information, there is no additional information relating
to proper use, precautions, or side effects for its use.
|
Previous section
